Found: 63
Select item for more details and to access through your institution.
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2945, doi. 10.3390/cancers16172945
- By:
- Publication type:
- Article
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 9, p. 1618, doi. 10.3390/healthcare10091618
- By:
- Publication type:
- Article
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1122977
- By:
- Publication type:
- Article
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 1, p. 63, doi. 10.1111/j.1742-7843.2012.00923.x
- By:
- Publication type:
- Article
Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1180997
- By:
- Publication type:
- Article
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01460-0
- By:
- Publication type:
- Article
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00786-z
- By:
- Publication type:
- Article
Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5231, doi. 10.3390/ijms21155231
- By:
- Publication type:
- Article
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 18, p. 4484, doi. 10.3390/ijms20184484
- By:
- Publication type:
- Article
Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00319
- By:
- Publication type:
- Article
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat.
- Published in:
- Digestive Diseases & Sciences, 2009, v. 54, n. 1, p. 193, doi. 10.1007/s10620-008-0344-5
- By:
- Publication type:
- Article
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat.
- Published in:
- Digestive Diseases & Sciences, 2008, v. 53, n. 12, p. 3170, doi. 10.1007/s10620-008-0299-6
- By:
- Publication type:
- Article
Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?
- Published in:
- Revue Immunite & Cancer, 2023, v. 7, n. 4, p. 159
- By:
- Publication type:
- Article
Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 918, doi. 10.1111/apt.17431
- By:
- Publication type:
- Article
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis—authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 9, p. 1370, doi. 10.1111/apt.17201
- By:
- Publication type:
- Article
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 10, p. 1037, doi. 10.1038/nbt.3662
- By:
- Publication type:
- Article
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60738-4
- By:
- Publication type:
- Article
Loss of Ambra1 promotes melanoma growth and invasion.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22772-2
- By:
- Publication type:
- Article
Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1603, doi. 10.1080/0284186X.2019.1633015
- By:
- Publication type:
- Article
Natural CD4<sup>+</sup> T-Cell Responses against Indoleamine 2,3- Dioxygenase.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034568
- By:
- Publication type:
- Article
Role of signal transduction and microRNAs on the immunogenicity of melanoma cells.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 169, doi. 10.1186/1479-5876-10-169
- By:
- Publication type:
- Article
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2023, v. 36, n. 2, p. 224, doi. 10.1111/pcmr.13072
- By:
- Publication type:
- Article
Midkine—A potential therapeutic target in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2021, v. 34, n. 5, p. 834, doi. 10.1111/pcmr.12967
- By:
- Publication type:
- Article
Proteomics to study cancer immunity and improve treatment.
- Published in:
- Seminars in Immunopathology, 2023, v. 45, n. 2, p. 241, doi. 10.1007/s00281-022-00980-2
- By:
- Publication type:
- Article
Principles of adoptive T cell therapy in cancer.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 49, doi. 10.1007/s00281-018-0703-z
- By:
- Publication type:
- Article
Acquired resistance to cancer immunotherapy.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 31, doi. 10.1007/s00281-018-0692-y
- By:
- Publication type:
- Article
Cancer immunotherapy in patients with preexisting autoimmune disorders.
- Published in:
- Seminars in Immunopathology, 2017, v. 39, n. 3, p. 333, doi. 10.1007/s00281-016-0595-8
- By:
- Publication type:
- Article
Potential use of rapamycin in HIV infection M. Donia et al. Rapamycin for HIV treatment.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 784, doi. 10.1111/j.1365-2125.2010.03735.x
- By:
- Publication type:
- Article
Molecular patterns of resistance to immune checkpoint blockade in melanoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47425-y
- By:
- Publication type:
- Article
More tricks with tetramers: a practical guide to staining T cells with peptide- MHC multimers.
- Published in:
- Immunology, 2015, v. 146, n. 1, p. 11, doi. 10.1111/imm.12499
- By:
- Publication type:
- Article
Transcriptomic signatures of tumors undergoing T cell attack.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 553, doi. 10.1007/s00262-021-03015-1
- By:
- Publication type:
- Article
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1771, doi. 10.1007/s00262-020-02760-z
- By:
- Publication type:
- Article
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 10, p. 1689, doi. 10.1007/s00262-019-02373-1
- By:
- Publication type:
- Article
Cancer immunotherapy in patients with brain metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 703, doi. 10.1007/s00262-018-2146-8
- By:
- Publication type:
- Article
Broadening the repertoire of melanoma-associated T-cell epitopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 609, doi. 10.1007/s00262-015-1664-x
- By:
- Publication type:
- Article
'Immunotherapy of cancer: present status and future promise': Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd-25th September 2013.
- Published in:
- 2014
- By:
- Publication type:
- Report
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1221, doi. 10.1007/s00262-011-1199-8
- By:
- Publication type:
- Article
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark.
- Published in:
- 2012
- By:
- Publication type:
- Report
Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells.
- Published in:
- Science Immunology, 2019, v. 4, n. 37, p. 1, doi. 10.1126/sciimmunol.aau9039
- By:
- Publication type:
- Article
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1360281
- By:
- Publication type:
- Article
Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2023.1320614
- By:
- Publication type:
- Article
Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1180997
- By:
- Publication type:
- Article
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases—A Danish Real-World Cohort.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2559, doi. 10.3390/cancers16142559
- By:
- Publication type:
- Article
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 964, doi. 10.3390/cancers16050964
- By:
- Publication type:
- Article
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5550, doi. 10.3390/cancers13215550
- By:
- Publication type:
- Article
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3828, doi. 10.3390/cancers12123828
- By:
- Publication type:
- Article
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8 + T Cells in Non-Melanoma Cancers Compared to Melanoma.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3344, doi. 10.3390/cancers12113344
- By:
- Publication type:
- Article